Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,196 | 195 | 93.9% |
| Education | $273.96 | 4 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $863.90 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $760.41 | 43 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $672.48 | 45 | $0 (2023) |
| ABBVIE INC. | $596.21 | 30 | $0 (2024) |
| Lilly USA, LLC | $323.55 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $295.73 | 21 | $0 (2024) |
| Amgen Inc. | $144.13 | 2 | $0 (2022) |
| PFIZER INC. | $141.69 | 3 | $0 (2023) |
| Allergan, Inc. | $130.38 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $121.01 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,346 | 41 | Galderma Laboratories, L.P. ($634.51) |
| 2023 | $1,178 | 51 | ABBVIE INC. ($214.72) |
| 2022 | $1,240 | 58 | Janssen Biotech, Inc. ($369.33) |
| 2021 | $705.24 | 49 | SUN PHARMACEUTICAL INDUSTRIES INC. ($220.60) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Immunology | ||||||
| 11/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $59.73 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $6.92 | General |
| 09/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $155.83 | General |
| 09/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: Immunology | ||||||
| 08/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 08/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $49.94 | General |
| 08/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $30.06 | General |
| 07/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Dermatology | ||||||
| 06/25/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: Immunology | ||||||
| 06/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $84.15 | General |
| 05/29/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $122.31 | General |
| Category: Immunology | ||||||
| 05/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $47.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 15 | 1,666 | 3,508 | $281,085 | $104,023 |
| 2021 | 25 | 2,267 | 4,588 | $425,788 | $166,909 |
| 2020 | 21 | 1,882 | 3,527 | $348,003 | $131,432 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 497 | 721 | $90,125 | $37,176 | 41.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 329 | 459 | $48,195 | $14,759 | 30.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 174 | 208 | $39,520 | $14,287 | 36.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 131 | 145 | $23,250 | $8,070 | 34.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 259 | 1,670 | $16,700 | $7,742 | 46.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 23 | 25 | $11,350 | $4,775 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 58 | $11,435 | $4,425 | 38.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 17 | 20 | $5,600 | $2,338 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $7,325 | $2,257 | 30.8% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 27 | 35 | $7,175 | $2,217 | 30.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 29 | 41 | $2,705 | $1,480 | 54.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 36 | $3,240 | $1,331 | 41.1% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 15 | 17 | $4,420 | $1,220 | 27.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 12 | $6,720 | $982.78 | 14.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 18 | 19 | $3,325 | $963.76 | 29.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 541 | 819 | $102,425 | $46,208 | 45.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 227 | 279 | $53,010 | $19,424 | 36.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 408 | 560 | $58,800 | $18,228 | 31.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 338 | 2,101 | $21,010 | $9,798 | 46.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 122 | 128 | $18,210 | $7,972 | 43.8% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2021 | 75 | 91 | $18,655 | $6,563 | 35.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 97 | 97 | $16,975 | $6,297 | 37.1% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 40 | 54 | $15,120 | $6,011 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 76 | $12,105 | $5,649 | 46.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2021 | 16 | 17 | $6,545 | $5,229 | 79.9% |
About Fallon Agahi
Fallon Agahi is a Physician Assistant healthcare provider based in Granite Bay, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1538456090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Fallon Agahi has received a total of $4,470 in payments from pharmaceutical and medical device companies, with $1,346 received in 2024. These payments were reported across 199 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,196).
As a Medicare-enrolled provider, Agahi has provided services to 5,815 Medicare beneficiaries, totaling 11,623 services with total Medicare billing of $402,364. Data is available for 3 years (2020–2022), covering 61 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Granite Bay, CA
- Active Since 07/06/2011
- Last Updated 11/14/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1538456090
Products in Payments
- TREMFYA (Drug) $650.40
- SKYRIZI (Biological) $348.94
- Winlevi (Drug) $226.86
- ILUMYA (Biological) $225.02
- COSENTYX (Drug) $205.98
- Ilumya (Biological) $204.27
- TALTZ (Drug) $201.24
- DUPIXENT (Biological) $173.27
- Otezla (Drug) $144.13
- BOTOX (Biological) $130.38
- OLUMIANT (Drug) $122.31
- CIBINQO (Drug) $116.20
- REMICADE (Biological) $110.01
- RINVOQ (Biological) $109.00
- COSENTYX (Biological) $89.75
- OPZELURA (Drug) $79.65
- ADBRY (Biological) $55.62
- HUMIRA (Biological) $38.80
- JUBLIA (Drug) $34.46
- ENSTILAR (Drug) $27.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Granite Bay
Wesley Garwood, Pa, PA
Physician Assistant — Payments: $149.99
Mr. Thomas Cowles, Pa-C, PA-C
Physician Assistant — Payments: $144.73
Ms. Musarrat Malik, Pa-C, PA-C
Physician Assistant
Coelithia Sosa, Pa, PA
Physician Assistant
Ganna Kozyk
Physician Assistant